-
公开(公告)号:US08227429B2
公开(公告)日:2012-07-24
申请号:US11828404
申请日:2007-07-26
申请人: Ralf Warrass , Fritz Blatter , Meinrad Brenner , Guixan Hu , Tamo Rager
发明人: Ralf Warrass , Fritz Blatter , Meinrad Brenner , Guixan Hu , Tamo Rager
CPC分类号: C07H17/08
摘要: This invention relates to a method for making macrolides, and, in particular, a method for making optionally substituted 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide and derivatives thereof, as well as uses of macrolides to make medicaments, methods of treatment using macrolides, and methods for making intermediates that, inter alia, may be used to make macrolides. This invention also relates to solvated and non-solvated crystalline forms of 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide, as well as methods for making such crystalline forms, medicaments comprising (or derived from) such crystalline forms, methods for making medicaments comprising (or derived from) such crystalline forms, methods of treatment using such crystalline forms, and kits comprising such crystalline forms.
-
公开(公告)号:US08518900B2
公开(公告)日:2013-08-27
申请号:US13359327
申请日:2012-01-26
申请人: Ralf Warrass , Fritz Blatter , Meinrad Brenner , Guixan Hu , Timo Rager
发明人: Ralf Warrass , Fritz Blatter , Meinrad Brenner , Guixan Hu , Timo Rager
CPC分类号: C07H17/08
摘要: Described are methods for making macrolides, and, in particular, a method for making optionally substituted 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide and derivatives thereof, as well as uses of macrolides to make medicaments, methods of treatment using macrolides, and methods for making intermediates that, among other uses, may be used to make macrolides. Also described are solvated and non-solvated crystalline forms of 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide, as well as methods for making such crystalline forms, medicaments comprising (or derived from) such crystalline forms, methods for making medicaments comprising (or derived from) such crystalline forms, methods of treatment using such crystalline forms, and kits comprising such crystalline forms.
摘要翻译: 描述了制备大环内酯类的方法,特别是制备任选取代的20,23-二哌啶基-5-O-碳霉糖基 - 太乐内酯及其衍生物的方法,以及大环内酯类制备药物的用途,使用大环内酯类的治疗方法 以及用于制造中间体的方法,除了其它用途之外,可以使用它们来制备大环内酯类。 还描述了20,23-二哌啶基-5-O-碳霉糖基 - 太乐内酯的溶剂化和非溶剂化结晶形式,以及制备这种结晶形式的方法,包含(或衍生自)这种结晶形式的药物,制备药物的方法 包括(或衍生自)这种结晶形式,使用这种结晶形式的处理方法,以及包含这种结晶形式的试剂盒。
-
公开(公告)号:US20120122808A1
公开(公告)日:2012-05-17
申请号:US13359327
申请日:2012-01-26
申请人: Ralf Warrass , Fritz Blatter , Meinrad Brenner , Guixan Hu , Timo Rager
发明人: Ralf Warrass , Fritz Blatter , Meinrad Brenner , Guixan Hu , Timo Rager
IPC分类号: A61K31/706 , A61P31/04 , C07H17/08
CPC分类号: C07H17/08
摘要: Described are methods for making macrolides, and, in particular, a method for making optionally substituted 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide and derivatives thereof, as well as uses of macrolides to make medicaments, methods of treatment using macrolides, and methods for making intermediates that, among other uses, may be used to make macrolides. Also described are solvated and non-solvated crystalline forms of 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide, as well as methods for making such crystalline forms, medicaments comprising (or derived from) such crystalline forms, methods for making medicaments comprising (or derived from) such crystalline forms, methods of treatment using such crystalline forms, and kits comprising such crystalline forms.
摘要翻译: 描述了制备大环内酯类的方法,特别是制备任选取代的20,23-二哌啶基-5-O-碳霉糖基 - 太乐内酯及其衍生物的方法,以及大环内酯类制备药物的用途,使用大环内酯类的治疗方法 以及用于制造中间体的方法,除了其它用途之外,可以使用它们来制备大环内酯类。 还描述了20,23-二哌啶基-5-O-碳霉糖基 - 太乐内酯的溶剂化和非溶剂化结晶形式,以及制备这种结晶形式的方法,包含(或衍生自)这种结晶形式的药物,制备药物的方法 包括(或衍生自)这种结晶形式,使用这种结晶形式的处理方法,以及包含这种结晶形式的试剂盒。
-
公开(公告)号:US20090042815A1
公开(公告)日:2009-02-12
申请号:US11828404
申请日:2007-07-26
申请人: Fritz Blatter , Meinrad Brenner , Monika Brink , Kerstin Fleischhauer , Guixian Hu , Hans Peter Niedermann , Timo Rager , Tanja Schweisel , Stephan Veit , Ralf Warrass , Heinz-Jorg Wennesheimer
发明人: Fritz Blatter , Meinrad Brenner , Monika Brink , Kerstin Fleischhauer , Guixian Hu , Hans Peter Niedermann , Timo Rager , Tanja Schweisel , Stephan Veit , Ralf Warrass , Heinz-Jorg Wennesheimer
IPC分类号: A61K31/7048 , C07H17/08 , A61P11/00
CPC分类号: C07H17/08
摘要: This invention relates to a method for making macrolides, and, in particular, a method for making optionally substituted 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide and derivatives thereof, as well as uses of macrolides to make medicaments, methods of treatment using macrolides, and methods for making intermediates that, inter alia, may be used to make macrolides. This invention also relates to solvated and non-solvated crystalline forms of 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide, as well as methods for making such crystalline forms, medicaments comprising (or derived from) such crystalline forms, methods for making medicaments comprising (or derived from) such crystalline forms, methods of treatment using such crystalline forms, and kits comprising such crystalline forms.
摘要翻译: 本发明涉及一种制备大环内酯类的方法,特别涉及制备任选取代的20,23-二哌啶基-5-O-碳霉糖基 - 太乐内酯及其衍生物的方法,以及大环内酯类制备药物的用途,方法 使用大环内酯的处理,以及制备中间体的方法,其特别可用于制备大环内酯。 本发明还涉及20,23-二哌啶基-5-O-碳霉糖基 - 太乐内酯的溶剂化和非溶剂化结晶形式,以及制备这种结晶形式的方法,包含(或衍生自)这种结晶形式的药物, 制造包含(或衍生自)这种结晶形式的药物,使用这种结晶形式的治疗方法,以及包含这种结晶形式的试剂盒。
-
公开(公告)号:US20110053875A1
公开(公告)日:2011-03-03
申请号:US12804847
申请日:2010-07-30
申请人: Fritz Blatter , Meinrad Brenner , Monika Brink , Kerstin Fleischhauer , Guixian Hu , Hans Peter Niedermann , Timo Rager , Tanja Schweisel , Stephan Veit , Ralf Warrass , Heinz-Jörg Wennesheimer
发明人: Fritz Blatter , Meinrad Brenner , Monika Brink , Kerstin Fleischhauer , Guixian Hu , Hans Peter Niedermann , Timo Rager , Tanja Schweisel , Stephan Veit , Ralf Warrass , Heinz-Jörg Wennesheimer
IPC分类号: A61K31/706 , C07H17/08 , A61P11/00 , A61P31/04
CPC分类号: C07H17/08
摘要: This invention relates to a method for making macrolides, and, in particular, a method for making optionally substituted 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide and derivatives thereof, as well as uses of macrolides to make medicaments, methods of treatment using macrolides, and methods for making intermediates that, inter alia, may be used to make macrolides. This invention also relates to solvated and non-solvated crystalline forms of 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide, as well as methods for making such crystalline forms, medicaments comprising (or derived from) such crystalline forms, methods for making medicaments comprising (or derived from) such crystalline forms, methods of treatment using such crystalline forms, and kits comprising such crystalline forms.
摘要翻译: 本发明涉及一种制备大环内酯类的方法,特别涉及制备任选取代的20,23-二哌啶基-5-O-碳霉糖基 - 太乐内酯及其衍生物的方法,以及大环内酯类制备药物的用途,方法 使用大环内酯的处理,以及制备中间体的方法,其特别可用于制备大环内酯。 本发明还涉及20,23-二哌啶基-5-O-碳霉糖基 - 太乐内酯的溶剂化和非溶剂化结晶形式,以及制备这种结晶形式的方法,包含(或衍生自)这种结晶形式的药物, 制造包含(或衍生自)这种结晶形式的药物,使用这种结晶形式的治疗方法,以及包含这种结晶形式的试剂盒。
-
公开(公告)号:US20130324763A1
公开(公告)日:2013-12-05
申请号:US13879198
申请日:2011-10-14
申请人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
发明人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
IPC分类号: C07C213/10
CPC分类号: C07C315/06 , C07B53/00 , C07C213/00 , C07C213/10 , C07D265/18 , C07C215/68
摘要: A process for the synthesis of chiral propargylic alcohols.
摘要翻译: 一种合成手性炔丙醇的方法。
-
公开(公告)号:US08957204B2
公开(公告)日:2015-02-17
申请号:US13879258
申请日:2011-10-14
申请人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
发明人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
IPC分类号: C07D265/18
CPC分类号: C07D265/18
摘要: The invention is directed to a process for the preparation of a cyclic carbamate starting with a chiral propargylic alcohol and/or a suitable salt thereof, which is reacted with a cyclization agent selected from phosgene, diphosgene, triphosgene and mixtures thereof, and in that the reaction is carried out in the presence of an aqueous base, and a water-immiscible organic solvent, said organic solvent mainly comprising at least one compound selected from C2-5-alkyl C2-5-carboxylates and mixtures of at least one C2-5-alkyl C2-5-carboxylate with at least one C5-8-alkane. Another aspect of the invention is directed to a process for the synthesis of said cyclic carbamate starting described above, wherein also a process for the preparation of the chiral propargylic alcohol is provided.
摘要翻译: 本发明涉及一种制备环状氨基甲酸酯的方法,其起始于手性炔丙醇和/或其合适的盐,其与选自光气,双光气,三光气及其混合物的环化剂反应, 反应在碱水溶液和水不混溶的有机溶剂的存在下进行,所述有机溶剂主要包含至少一种选自C 2-5 - C 2-8 - C 2-8 - 羧酸烷基酯的化合物和至少一种C2-5-羧酸盐的混合物 - 烷基C2-5-羧酸酯与至少一种C5-8-烷烃。 本发明的另一方面涉及一种合成上述环状氨基甲酸酯的方法,其中还提供了制备手性炔丙醇的方法。
-
公开(公告)号:US20130217875A1
公开(公告)日:2013-08-22
申请号:US13879258
申请日:2011-10-14
申请人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
发明人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
IPC分类号: C07D265/18
CPC分类号: C07D265/18
摘要: The invention is directed to a process for the preparation of a cyclic carbamate starting with a chiral propargylic alcohol and/or a suitable salt thereof, which is reacted with a cyclisation agent selected from phosgene, diphosgene, triphosgene and mixtures thereof, and in that the reaction is carried out in the presence of an aqueous base, and a water-immiscible organic solvent, said organic solvent mainly comprising at least one compound selected from C2-5-alkyl C2-5-carboxylates and mixtures of at least one C2-5-alkyl C2-5-carboxylate with at least one C5-8-alkane. Another aspect of the invention is directed to a process for the synthesis of said cyclic carbamate starting described above, wherein also a process for the preparation of the chiral propargylic alcohol is provided.
摘要翻译: 本发明涉及一种由手性炔丙醇和/或其合适的盐开始制备环状氨基甲酸酯的方法,其与选自光气,双极光,三光气及其混合物的环化剂反应, 反应在碱水溶液和水不混溶的有机溶剂的存在下进行,所述有机溶剂主要包含至少一种选自C 2-5 - C 2-8 - C 2-8 - 羧酸烷基酯的化合物和至少一种C2-5-羧酸盐的混合物 - 烷基C2-5-羧酸酯与至少一种C5-8-烷烃。 本发明的另一方面涉及一种合成上述环状氨基甲酸酯的方法,其中还提供了制备手性炔丙醇的方法。
-
公开(公告)号:US20130211077A1
公开(公告)日:2013-08-15
申请号:US13879221
申请日:2011-10-14
申请人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
发明人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
IPC分类号: C07D265/18
CPC分类号: C07D265/18
摘要: The invention is directed to a process for the preparation of a cyclic carbamate starting with o-aminobenzyl alcohol and/or a suitable salt thereof, which is reacted with a cyclisation agent selected from phosgene, diphosgene, triphosgene and mixtures thereof, and in that the reaction carried out in the presence of an aqueous base, and a water-immiscible organic solvent, said organic solvent mainly comprising at least one compound selected from C2-5-alkyl C2-5-carboxylates and mixtures of at least one C2-5-alkyl C2-5-carboxylate with at least one C5-8-alkane.
摘要翻译: 本发明涉及一种由邻氨基苄醇和/或其合适的盐开始制备环状氨基甲酸酯的方法,其与选自光气,双极光,三光气及其混合物的环化剂反应, 在碱水溶液和水不混溶的有机溶剂的存在下进行反应,所述有机溶剂主要包含至少一种选自C 2-5烷基C 2-5 - 羧酸盐的化合物和至少一种C2-5-羧酸盐的混合物, 具有至少一个C 5-8烷烃的C2-5-羧酸烷基酯。
-
公开(公告)号:US08969550B2
公开(公告)日:2015-03-03
申请号:US13879221
申请日:2011-10-14
申请人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
发明人: Meinrad Brenner , Erick M. Carreira , Nicka Chinkov , Miriam Lorenzi , Aleksander Warm , Lothar Zimmermann
IPC分类号: C07D265/18
CPC分类号: C07D265/18
摘要: The invention is directed to a process for the preparation of a cyclic carbamate starting with o-aminobenzyl alcohol and/or a suitable salt thereof, which is reacted with a cyclization agent selected from phosgene, diphosgene, triphosgene and mixtures thereof, and in that the reaction carried out in the presence of an aqueous base, and a water-immiscible organic solvent, said organic solvent mainly comprising at least one compound selected from C2-5-alkyl C2-5-carboxylates and mixtures of at least one C2-5-alkyl C2-5-carboxylate with at least one C5-8-alkane.
摘要翻译: 本发明涉及一种由邻氨基苄醇和/或其合适的盐开始制备环状氨基甲酸酯的方法,其与选自光气,双极光,三光气及其混合物的环化剂反应, 在碱水溶液和水不混溶的有机溶剂的存在下进行反应,所述有机溶剂主要包含至少一种选自C 2-5烷基C 2-5 - 羧酸盐的化合物和至少一种C2-5-羧酸盐的混合物, 具有至少一个C 5-8烷烃的C2-5-羧酸烷基酯。
-
-
-
-
-
-
-
-
-